Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTP4A3 | O75365 | 1/20 | 0.57 |
| ▸ | PTP4A2 | Q12974 | 1/20 | 0.57 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ABL1 | P00519 | 2/20 | 0.42 |
| ▸ | BCR | P11274 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23530158 | 0.93 | PTP4A3 (0.54) | PTP4A3PTP4A2PTP4A1CYP3A4CYP1A2 | |
| SCHEMBL2269598 | 0.93 | PTP4A3 (0.54) | PTP4A3PTP4A2PTP4A1CYP3A4CYP1A2 | |
| SCHEMBL8331758 | 0.88 | HPGD (0.49) | PTP4A3PTP4A2PTP4A1MAPTKMT2A | |
| SCHEMBL29601206 | 0.84 | MAPT (0.67) | CYP3A4CYP1A2CYP2C9CYP2B6CYP2D6 | |
| SCHEMBL168150 | 0.84 | MAPT (0.67) | CYP3A4CYP1A2CYP2C9CYP2B6CYP2D6 | |
| SCHEMBL20162247 | 0.84 | PTP4A3 (0.43) | PTP4A3PTP4A2PTP4A1CYP3A4CYP1A2 | |
| SCHEMBL20395525 | 0.83 | MAPT (0.58) | CYP3A4CYP1A2CYP2C9CYP2B6CYP2D6 | |
| SCHEMBL20162246 | 0.81 | PTP4A3 (0.41) | PTP4A3PTP4A2PTP4A1CYP1A2CYP2C9 | |
| SCHEMBL11769950 | 0.81 | PTP4A3 (0.45) | PTP4A3PTP4A2PTP4A1MAPTKMT2A | |
| SCHEMBL8842877 | 0.80 | PTP4A3 (0.51) | PTP4A3PTP4A2PTP4A1CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12453682-B2 | Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative | L'ORÉAL (FR) | 2025-10-28 | — | — | US | claimed |
| US-20230044544-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2023-02-09 | — | — | US | claimed |
| EP-4076677-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2022-10-26 | — | — | EP | claimed |
| WO-2021122039-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2021-06-24 | — | — | WO | claimed |
| EP-1635777-B1 | PHOTOSTABLE ORGANIC SUNSCREEN COMPOSITION | MERCK PATENT GMBH (DE) | 2012-06-06 | — | — | EP | claimed |
| EP-1747773-B1 | Photostable organic sunscreen compositions with antioxidant properties | MERCK PATENT GMBH (DE) | 2010-08-04 | — | — | EP | claimed |
| EP-1406582-B1 | PHOTOSTABLE ORGANIC SUNSCREEN COMPOUNDS WITH ANTIOXIDANT PROPERTIES AND COMPOSITIONS OBTAINED THEREFROM | MERCK PATENT GMBH (DE) | 2006-10-25 | — | — | EP | claimed |
| CN-1798538-A | Photostable organic sunscreen composition | MERCK PATENT GMBH (DE) | 2006-07-05 | — | — | CN | claimed |
| US-12453682-B2 | Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative | L'ORÉAL (FR) | 2025-10-28 | — | — | US | disclosed |
| US-20230044544-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2023-02-09 | — | — | US | disclosed |
| EP-4076677-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2022-10-26 | — | — | EP | disclosed |
| WO-2021122039-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2021-06-24 | — | — | WO | disclosed |
| US-20210161783-A1 | USE OF SPECIFIC BENZYLIDENE MALONATES FOR PROTECTING THE SKIN FROM CHEMICALLY INDUCED STRESS | MERCK PATENT GMBH (DE) | 2021-06-03 | — | — | US | disclosed |
| US-20180207080-A1 | COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2018-07-26 | — | — | US | disclosed |
| EP-3322400-A1 | COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS | Merck Patent GmbH (DE) | 2018-05-23 | — | — | EP | disclosed |
| CN-1798538-A | Photostable organic sunscreen composition | MERCK PATENT GMBH (DE) | 2006-07-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230044544-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | HAAO, HAO2, HPD | PTP4A3 1288/4885PTP4A2 1754/4885PTP4A1 1193/4885 |
| US-12453682-B2 | Composition comprising at least 5% by weight of titanium oxides, an α-cyanodiphenylacrylate derivative and a 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative | HAAO, HPD, P4HA1 | PTP4A3 1306/4885PTP4A2 1805/4885PTP4A1 1191/4885 |
| US-20180207080-A1 | COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS | LPO, CAT, GPX4 | PTP4A3 3582/4885PTP4A2 4139/4885PTP4A1 3983/4885 |
| US-20210161783-A1 | USE OF SPECIFIC BENZYLIDENE MALONATES FOR PROTECTING THE SKIN FROM CHEMICALLY INDUCED STRESS | MAL2, GAA, ME2 | PTP4A3 1356/4885PTP4A2 1439/4885PTP4A1 1509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.